| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.0008 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |